Diebold Nixdorf (DBD) Misses Q2 EPS by 18c
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $66.59 -1.84%
Financial Fact:
Net income attributable to Diebold, Incorporated: -21.1M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Net income attributable to Diebold, Incorporated: -21.1M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q2 EPS of $0.10, $0.18 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $943.5 million versus the consensus estimate of $959.2 million.
GUIDANCE:
Diebold Nixdorf sees Q3 2021 revenue of $4-4.1 billion, versus the consensus of $4.08 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Humana reaffirms 2026 earnings guidance ahead of investor meetings
- Why UBS thinks this European chipmaker is still undervalued despite its premium valuation
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
